key: cord-0850021-0e87kxyc
authors: Liu, Michael; Richard, Lucie; Campitelli, Michael A.; Nisenbaum, Rosane; Dosani, Naheed; Dhalla, Irfan A.; Wadhera, Rishi K.; Shariff, Salimah Z.; Hwang, Stephen W.
title: Drug Overdoses During the COVID‐19 Pandemic Among Recently Homeless Individuals
date: 2022-02-14
journal: Addiction
DOI: 10.1111/add.15823
sha: 9b7d525d8864574220af6bb4fd7f39dad21d6080
doc_id: 850021
cord_uid: 0e87kxyc

AIMS: To examine how weekly rates of emergency department (ED) visits for drug overdoses changed among individuals with a recent history of homelessness (IRHH) and their housed counterparts during the pre‐pandemic, peak, and re‐opening periods of the first wave of the COVID‐19 pandemic, using corresponding weeks in 2019 as a historical control. DESIGN: Population‐based retrospective cohort study conducted between September 30, 2018 and September 26, 2020. SETTING: Ontario, Canada. PARTICIPANTS: A total of 38 617 IRHH, 15 022 369 housed individuals, and 186 858 low‐income housed individuals matched on age, sex, rurality, and comorbidity burden. MEASUREMENTS: ED visits for drug overdoses of accidental and undetermined intent. FINDINGS: Average rates of ED visits for drug overdoses between January and September 2020 were higher among IRHH compared with housed individuals (rate ratio [RR], 148.0; 95% CI, 142.7–153.5) and matched housed individuals (RR, 22.3; 95% CI, 20.7–24.0). ED visits for drug overdoses decreased across all groups by ~20% during the peak period (March 17 to June 16, 2020) compared with corresponding weeks in 2019. During the re‐opening period (June 17 to September 26, 2020), rates of ED visits for drug overdoses were significantly higher among IRHH (RR, 1.56; 95% CI, 1.44–1.69), matched housed individuals (RR, 1.25; 95% CI, 1.08–1.46), and housed individuals relative to equivalent weeks in 2019 (RR, 1.07; 95% CI, 1.02–1.11). The relative increase in drug overdose ED visits among IRHH was larger compared with both matched housed individuals (P = 0.01 for interaction between group and year) and housed individuals (P < 0.001) during this period. CONCLUSIONS: Recently homeless individuals in Ontario, Canada experienced disproportionate increases in ED visits for drug overdoses during the re‐opening period of the COVID‐19 pandemic compared with housed people.

Although the direct impacts of the coronavirus disease 2019 (COVID- 19) pandemic have been substantial and well-documented, concerns have been raised about the numerous indirect impacts of the pandemic. Public health measures such as stay-at-home orders, closure of public spaces, and social distancing, although critical for reducing viral transmission, have had negative consequences for mental health [1, 2] . Recent evidence suggests that social isolation, economic strain, and uncertainty about the future during the pandemic have increased psychological distress and loneliness [3] . Substance use has intensified as a result of coping with pandemic-related stressors [4] . Deaths from drug overdoses and emergency department (ED) visits for substance-related conditions have all increased significantly during the pandemic among the general population in North America [5] [6] [7] [8] . Morbidity and mortality attributable to substance use have likely been exacerbated by closures and reductions in the availability of treatment facilities and harm reduction services during the pandemic [9, 10] . Because of stay-at-home-orders, fears of being exposed to COVID-19, and caregiving and occupational responsibilities, many people delayed or avoided seeking necessary health care and supports, reflected in reductions in overall primary care visits and hospital use during the pandemic [11] [12] [13] . However, very little is currently known about the indirect toll of the COVID-19 pandemic on vulnerable populations such as individuals experiencing homelessness.

A growing body of evidence shows that the burden of COVID -19 infection has been much larger among the homeless population relative to the general population [14, 15] . Many homeless shelters are high-risk environments for viral transmission, and rates of health conditions that elevate risk of COVID-19 mortality are much higher in this population [16, 17] . A recent population-based study in Ontario, Canada found that rates of COVID-19 infection, hospitalization, and death among individuals with a recent history of homelessness were several times higher than those of the community-dwelling population, respectively [18] . The outsized direct impact of the pandemic on the homeless population and their pre-existing risk factors present concerns about disproportionate indirect impacts, particularly in relation to substance-related outcomes. Drug overdose is a leading cause of morbidity and mortality in the homeless population and baseline rates of substance use disorders are several-fold higher among individuals experiencing homelessness compared to their housed counterparts [19] [20] [21] . Individuals experiencing homelessness stand to benefit greatly from substance use treatments and harm reduction services [22] . Yet, this population faces tremendous systemic and structural barriers to health care and supports, which have been further exacerbated by the COVID-19 pandemic [16] .

This study had three main objectives for understanding the indirect impacts of the COVID-19 pandemic on individuals experiencing homelessness. First, it sought to quantify the relative rates of ED visits for drug overdoses in 2020 among individuals with a recent history of homelessness (IRHH) compared to housed individuals. Second, it aimed to describe how rates of ED visits for drug overdoses changed during the 2020 pandemic among IRHH and their housed counterparts, using 2019 as a historical control. Third, it assessed whether changes in ED visits for drug overdoses between 2019 and 2020 were different between IRHH and housed individuals.

We conducted a retrospective population-based cohort study in Ontario-the most populous province of Canada with a population of 14.7 million as of 2020-using health administrative data. Ontario has a publicly funded healthcare system that provides universal access to essential medical and hospital services. Datasets were linked using unique encoded identifiers and analyzed at ICES. ICES is an independent, non-profit research institute whose legal status under Ontario's health information privacy law allows it to collect and analyze health care and demographic data, without consent, for health system evaluation and improvement. This study followed the Reporting of Studies Conducted Using Observational Routinely Collected Data (RECORD) reporting guidelines [23] .

We used a number of data sources to define participants, outcomes, 

All participants were followed from September 30, 2018 until September 26, 2020-the latest date, for which complete data were available at the time of analysis. Individuals were excluded if they died or entered long-term care on or before September 30, 2018 or if they did not have any contact with the healthcare system in the past 9 years (to ensure participants were living in Ontario). We defined three groups of participants. The first group was IRHH, which included all individuals eligible for Ontario Health Insurance Plan (OHIP) coverage and identified to be experiencing homelessness between September 30, 2018 and September 26, 2020 through an established, previously described algorithm [24] . In brief, the algorithm was able to identify IRHH if they were documented to be experiencing homelessness during a hospital-based health care encounter or had a residential address associated with shelter services during the study period. The second group consisted of all Ontario residents eligible for OHIP coverage and were not identified as having a recent history of homelessness. This group will be referred to as housed individuals for brevity. The third group was created by restricting the second group to those with at least one hospital-based health care encounter during the study period and living in a neighborhood in the lowest income quintile. This group was also matched 5:1 to the IRHH group based on age (AE2 years), sex (exact), level of rurality (exact), and Charlson Comorbidity Index (CCI) score (exact).

Greedy matching was used to produce matched samples with balanced covariates by finding the most optimal match for the first record, removing that record from further consideration, and repeating the process until all records have been matched [25] . The CCI score is a widely used and validated measure for comorbidity adjustment with administrative health data [26] .

The primary outcome of this study was ED visits for drug overdoses.

International Classification of Diseases, 10th Revision codes X40-X44 and Y10-Y14 were used to identify ED visits for unintentional drug overdoses and those of undetermined intent in the National Ambulatory Care Reporting System database. Outcomes were ascertained between January 5 and September 26, 2020, along with corresponding weeks in 2019.

We obtained sociodemographic characteristics for all groups at the start of the observation window (September 30, 2018), including age, sex, neighborhood income quintile, and level of rurality. To compare comorbidity burden across groups, we ascertained CCI scores (calculated using hospitalization data from the past 2 years), a past diagnosis of asthma or chronic obstructive pulmonary disease (COPD), diabetes, congestive heart failure, hypertension, chronic liver disease, and a recent cancer diagnosis (past 2 years). Additionally, we measured care for psychotic disorders, non-psychotic mental health disorders, and substance use disorders and the number of outpatient visits in the year before the observation window.

One-way analysis of variance, Kruskal-Wallis, Cochran-Armitage, and χ 2 tests were used to compare group characteristics at baseline between IRHH and either housed individuals or matched housed indi-

Ontarians, we also reported standardized differences between groups, which assess differences between group means as a percentage of the pooled standard deviation. Standardized differences of 0.1 or more were considered meaningful [27] .

For descriptive purposes, we first calculated weekly rates (per 100 000 individuals) of ED visits for drug overdoses in each group throughout the study period, using the cohort at risk that week as the denominator. Individuals were censored if they died or entered longterm care. Weekly rate ratios (RR) were calculated by dividing group weekly rates in 2020 with corresponding weekly rates in 2019.

Three periods of interest in 2020 were defined for this study based on two major events during the first wave of the COVID-19 pandemic in Ontario. The first event was the initial declaration of a state of emergency and province-wide lockdown in Ontario, which occurred on March 17, 2020. The second event was the staggered province-wide re-opening in Ontario, which began in the middle of June 2020. Therefore, the periods of January 5-March 16, March 17-June 16, and June 17-September 26 were designated as the prepandemic, peak, and re-opening periods, respectively.

Poisson regression models with population size offsets were fit to compute RRs and 95% CIs for drug overdose ED visits across groups between January 2020 and September 2020. Separate models were then fit for each group and period to compare weekly rates of ED visits for drug overdoses in 2020 to corresponding weekly rates in

were added to another set of models to evaluate whether changes in ED visits for drug overdoses between 2019 and 2020 were different between groups for each period.

All tests were two-sided with P < 0.05 defining statistical significance. Analyses were performed using R 4.0.0 and SAS 9.4. This study was approved by the Research Ethics Board of Unity Health Toronto.

Analyses were not pre-registered and, therefore, results presented in this study should be considered exploratory.

We identified a total of 38 617 IRHH, 15 shown in Supporting information Appendix Figure S2 . Average rates between January 2020 and September 2020 were 281.3 among IRHH, 12.6 among matched housed individuals, and 1.9 among housed individuals ( During the pre-pandemic period, the relative increase in ED visits for drug overdoses between 2019 and 2020 was larger for IRHH compared to housed individuals (P = 0.03 for interaction between group and year). During the re-opening period, the relative increase in ED visits for drug overdoses between 2019 and 2020 was larger for IRHH compared to both matched housed individuals (P = 0.01) and

housed individuals (P < 0.001).

In Ontario, average rates of ED visits for drug overdoses between January and September 2020 were considerably higher among IRHH [10, 28, 29] . These disruptions may have resulted in particularly negative consequences for individuals experiencing homelessness.

The burden of drug overdoses was already much larger among the homeless population before the pandemic given higher rates of substance use disorders, greater obstacles to substance use treatment, and harsher circumstances associated with the day-to-day T A B L E 2 Events, average rates, and rate ratios of emergency department visits for drug overdoses across groups, January 2020 to September 2020 experiences of homelessness [21, 22, 30] . This population also continues to contend with other structural barriers to care, such as lack of insurance coverage, competing priorities, and provider-level stigma [31] [32] [33] . Telehealth and virtual care have filled some gaps in the treatment of substance-related disorders during the pandemic, but access to these services still remains a challenge for unhoused individuals [34, 35] . Our findings demonstrate an unequivocal need for more accessible and tailored harm reduction, treatment, and recovery support services for the homeless population.

This study also found that increases in ED visits for drug overdoses occurred during the pre-pandemic period among recently homeless individuals. The rise in overdoses before and during the reopening period of the pandemic may be attributable, in part, to an increasingly tainted and toxic unregulated drug supply in Ontario and other jurisdictions, with reported contaminants including synthetic opioids and novel benzodiazepines [36, 37] . Recent studies of characteristics of drug overdose deaths occurring just before and during the COVID-19 pandemic in Rhode Island and Illinois reported many more fatalities because of synthetic opioids such as fentanyl [38, 39] . Usage of high-potency and adulterated illicit drugs has been further fueled by pandemic-related disruptions in regular drug supplies and sources across Canada [40] .

Greater supports are urgently needed for individuals experiencing homelessness given substantially higher rates and larger increases in ED visits for drug overdoses among this population before and during the re-opening period of the COVID-19 pandemic. Programs and services such as supervised consumption facilities, low-barrier opioid agonist therapies, and tailored office-based addiction treatments have been shown to reduce drug-related morbidity and mortality in the homeless population [22, 41, 42] . The high dual burden of substance use and mental health disorders in this population also necessitates more comprehensive interventions including on-site and traumainformed case management and psychiatric services [21, 43] . One relevant model of care during the pandemic was developed by the City and County of San Francisco, combining hotel-based COVID-19 isolation and quarantine with on-site case management, harm reduction services, pharmacotherapy, telemedicine addiction consultations, and behavioral health supports [44] . Perhaps most importantly, reducing the persistently higher burden of substance-related difficulties in this population during and beyond the pandemic will require addressing fundamental risk factors such as homelessness and socioeconomic inequities [45, 46] .

Further research is needed to understand factors contributing to the reductions in ED visits for drug overdoses during the peak period and subsequent increases during the re-opening period. These patterns have also been reported in the United States among the general population [7, 47] . One potential contributor is that avoidance of hospital-based care was highest during the peak period because of social distancing policies and fears of contracting COVID-19 [13] .

Emerging evidence demonstrates significantly higher rates of refusing transportation to the ED for drug overdoses during the peak period [48, 49] . This is also consistent with the 40%-60% reductions in overall ED visits and hospital admissions observed during the first wave [11, 50] . Relative reductions during the peak period in this study were smaller, but this is likely because many substance-related emergency department visits are precipitated by medical emergencies rather than discretionary care-seeking [51] . A second potential contributor is that the unregulated drug supply may have continued to become more toxic as the pandemic progressed, resulting in more severe overdoses for which care could not be deferred [36, 40] . One final potential contributor is the movement of individuals experiencing homelessness into temporary housing facilities during the pandemic given high risk of viral transmission in congregate shelters [52] . This may have reduced overdoses given the strong link between the experience of homelessness and drug overdoses [19, 53, 54] . The rebound observed in the re-opening period may be explained by movement of residents out of such temporary housing facilities or a decline in the potential 

The mental health consequences of COVID-19 and physical distancing: The need for prevention and early intervention

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

Psychological distress and loneliness reported by US adults

Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US

Measuring the burden of opioidrelated mortality in Ontario, Canada, during the COVID-19 pandemic

Drug overdose deaths before and after shelter-in-place orders during the COVID-19 pandemic in San Francisco

Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic

Mortality from drug overdoses, homicides, unintentional injuries, motor vehicle crashes, and suicides during the pandemic

Canadian Centre on Substance Use and Addiction. Impacts of the COVID-19 Pandemic on Substance Use Treatment Capacity in Canada

Trends in filled naloxone prescriptions before and during the COVID-19 pandemic in the United States

The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Aff

Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario

Delay or avoidance of medical care because of COVID-19-related concerns -United States

Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston

Nesbitt R Seroprevalence and risk factors of exposure to COVID-19 in homeless people

Health care for homeless people

COVID-19 and people experiencing homelessness: Challenges and mitigation strategies

Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: A retrospective cohort study. C Open

Drug overdose mortality among people experiencing homelessness

Mortality among homeless adults in Boston: Shifts in causes of death over a 15-year period

The prevalence of mental disorders among homeless people in high-income countries: An updated systematic review and meta-regression analysis

Clinical guideline for homeless and vulnerably housed people, and people with lived homelessness experience

The REporting of studies conducted using observational routinely-collected health data (RECORD) statement

Validation study of health administrative data algorithms to identify individuals experiencing homelessness and estimate population prevalence of homelessness in Ontario

Matching methods for causal inference: A review and a look forward

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries

Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research

Collision of the COVID-19 and addiction epidemics

Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: A global survey. Front Psych

Homeless women's service use, barriers, and motivation for participating in substance use treatment

Factors associated with the health care utilization of homeless persons

The unmet health care needs of homeless adults: A national study

Primary healthcare needs and barriers to care among Calgary's homeless populations

Use of telehealth in substance use disorder services during and after COVID-19: Online survey study

Telehealth for substance-using populations in the age of coronavirus disease 2019: Recommendations to enhance adoption

Changing Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19

What's in Toronto's Drug Supply? Results from Samples Checked by Toronto's Drug Checking Service

Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island

Unintentional opioid overdose death characteristics in Illinois before and during the COVID-19 era

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder

Office-based addiction treatment retention and mortality among people experiencing homelessness

The effectiveness of assertive community treatment for homeless populations with severe mental illness: A meta-analysis

Assessment of a hotel-based COVID-19 isolation and quarantine strategy for persons experiencing homelessness

Impact of work therapy on health status among homeless, substance-dependent veterans: A randomized controlled trial

Substance use outcomes among homeless clients with serious mental illness: Comparing housing first with treatment first programs

How emergency department visits for substance use disorders have evolved during the early COVID-19 pandemic

Factors associated with voluntary refusal of emergency medical system transport for emergency Care in Detroit during the early phase of the COVID-19 pandemic

Signal of increased opioid overdose during COVID-19 from emergency medical services data

Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US

Prevalence and predictors of involuntary psychiatric hospital admissions in Ontario, Canada: A population-based linked administrative database study

Assessment of a hotelbased protective housing program for incidence of SARS-CoV-2 infection and Management of Chronic Illness among Persons Experiencing Homelessness

Association between homelessness and opioid overdose and opioid-related hospital admissions/emergency department visits

Prevalence of and risk factors associated with nonfatal overdose among veterans who have experienced homelessness

Housing and overdose: An opportunity for the scale-up of overdose prevention interventions?

Everyone Counts

Drug Overdoses During the COVID-19 Pandemic Among Recently Homeless Individuals